Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,154 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06169046RecruitingPhase 2
Clenbuterol for spinal and bulbar muscular atrophy
This study tests if clenbuterol (a medication that may help strengthen muscles) can improve symptoms in people with spinal and bulbar muscular atrophy (SBMA, also called Kennedy's disease). It compares clenbuterol to a placebo (a dummy pill) over several months.
Padova, PDAges 18–75 - NCT05405868RecruitingPhase 3
Nicotinamide for early to moderate open-angle glaucoma
This trial tests whether nicotinamide (a form of vitamin B3) can slow vision changes from open-angle glaucoma. It compares nicotinamide versus a placebo (inactive pill) in adults with early to moderate disease.
Belfast, Northern IrelandAges 18 years+ - NCT06425224RecruitingPhase 3
TENS therapy for premature ejaculation
This trial tests if a painless electrical nerve stimulation (TENS) treatment can help men with premature ejaculation last longer and feel more in control. It's for men who have had this condition for at least 6 months and are in a stable relationship.
Mexico CityAges 18–62 - NCT06064669Recruiting
Metformin for healthy live birth in women with prediabetes
This study tests if metformin, a drug that helps control blood sugar, can improve the chance of a healthy live birth in women with prediabetes who are doing in vitro fertilization (IVF). It aims to see if treating prediabetes before and during early pregnancy leads to better outcomes.
Jinan, ShandongAges 20–40 - NCT07846371Recruiting
Dietary supplement to lower PFAS levels in firefighters
This trial tests whether a daily dietary supplement can reduce levels of PFAS chemicals in the blood. If you are a male firefighter with past exposure to PFAS, this study might help you lower these chemicals.
Chicago, IllinoisAges 18 years+ - NCT07845487RecruitingPhase 2
Study of PALI-2108 for moderate to severe ulcerative colitis
This trial tests an experimental drug called PALI-2108 against a placebo (a dummy treatment) for people with moderate to severe ulcerative colitis. It aims to see if PALI-2108 can help reduce symptoms and improve quality of life.
Sun City, ArizonaAges 18–75 - NCT06464744Recruiting
Can brain stimulation help after spinal cord injury?
This trial tests whether repetitive transcranial magnetic stimulation (rTMS), a non-invasive treatment that uses magnetic pulses to stimulate the brain, can improve movement and function in people with chronic spinal cord injury. It may help if you have some movement left below your injury level.
OsloAges 18–80 - NCT07831317Recruiting
Probiotic for digestive comfort in women
This study tests a daily probiotic supplement to see if it helps with gas and bloating in women who also have signs of hormonal imbalance. If you qualify, you'll take the supplement and track your symptoms over the study period.
San Francisco, CaliforniaAges 25–45 - NCT07833579Enrolling by invitation
Beetroot juice and basketball performance in female players
This trial tests whether drinking beetroot juice improves physical performance like jumping and sprinting in female basketball players. Participants will follow a supplement routine and complete performance tests.
Madrid, MadridAges 18–35 - NCT07820085RecruitingPhase 2/Phase 3
Oral treatment for light sensitivity in EPP and XLP
This study tests an oral medication, PORT-77, to reduce pain and sensitivity to sunlight in people with EPP or XLP. It may help those who experience symptoms shortly after sun exposure.
Huntington Beach, CaliforniaAges 12 years+ - NCT07818629RecruitingPhase 1
Testing a vaccine to prevent stomach flu in healthy adults
This trial tests an investigational vaccine called INT101 to see if it can prevent norovirus, a common cause of stomach flu (vomiting and diarrhea). It is given to healthy adults to check its safety and how well it works before moving to larger studies.
SeoulAges 19–48 - NCT07817875RecruitingPhase 3
Tirzepatide for weight loss in children aged 6 to under 12
This study tests a once-weekly medication called tirzepatide to help children aged 6 to under 12 with obesity lose weight. It compares the medication to a placebo (inactive shot) to see if it safely helps with weight loss in this age group.
Tucson, ArizonaAges 6–11 - NCT07815561RecruitingPhase 1
Testing a new drug for safety in healthy adults
This study tests a new medicine called SAB01 in healthy adults to see if it is safe and how the body handles it. It is a first-in-human trial, meaning this is the first time the drug is given to people.
Cypress, CaliforniaAges 18–55 - NCT07809321Enrolling by invitation
Beta-alanine effects on performance in female rugby players
This study tests whether a daily supplement called beta-alanine can improve muscle performance and heart health in female rugby players. It might help you play better and recover faster.
Madrid, MadridAges 18–40 - NCT07799493RecruitingPhase 4
Studying caplyta for adults with social anxiety disorder
This study tests whether the medication caplyta (lumateperone) helps reduce symptoms of social anxiety disorder compared to a placebo. If it works, it could give people a new treatment option.
New York, New YorkAges 18–65 - NCT07792876Recruiting
Testing ketone and carbohydrate supplements in trained cyclists
This study is testing how taking ketone and carbohydrate supplements affects performance in trained cyclists. It is looking for male amateur cyclists who train regularly and have a high fitness level.
Ribeirão Preto, São PauloAges 20–50 - NCT04257487RecruitingPhase 3
Sulodexide to prevent blood clots from coming back
This study tests sulodexide (a blood-vessel protective medicine) to help stop deep leg blood clots or lung clots from returning after you’ve already been treated. It may help people with higher bleeding risk who are taking or recently finished standard anticoagulant medicines.
RozzanoAges 75 years+ - NCT07790770RecruitingPhase 1
A study of a new drug in healthy adults
This study tests a new drug called CMS-F021 in healthy volunteers. It aims to see how the drug behaves in the body after single and multiple doses.
BeijingAges 18–55 - NCT07791043RecruitingPhase 2
Efimosfermin alfa for alcohol-related liver disease
This study tests an investigational medicine called efimosfermin alfa to see if it is safe and effective for people with liver damage caused by heavy drinking. The medicine is compared to a placebo (a dummy treatment).
Topeka, KansasAges 18–75 - NCT07782957RecruitingPhase 3
New shot for severe nasal polyps with ongoing sinus symptoms
This study tests an experimental medication called felcorekibart, given as an injection, to see if it reduces nasal polyps and improves sinus symptoms like congestion and loss of smell. It is for adults who have had nasal polyps for at least a year and have already tried standard treatments like steroid sprays or pills, or had surgery.
Sherman Oaks, CaliforniaAges 18 years+ - NCT07783542RecruitingPhase 2
Treatment for moderate to severe hidradenitis suppurativa
This study tests a new medication called ORKA-002 to see if it can reduce the number of painful bumps and sores in people with moderate to severe hidradenitis suppurativa (a chronic skin condition). It may be an option for people who have not had success with antibiotic treatments.
Birmingham, AlabamaAges 18–79 - NCT07780643RecruitingPhase 3
Asthma study for uncontrolled asthma on inhaled steroids
This study is testing an investigational medication for people with uncontrolled asthma. Participants must have moderate-to-severe asthma, be on appropriate maintenance therapy, and meet specific safety criteria.
Miami Lakes, FloridaAges 12–80 - NCT07780656RecruitingPhase 3
Felcorekibart for chronic obstructive pulmonary disease (COPD)
This study tests a new medicine, felcorekibart, to see if it can reduce COPD flare-ups better than a placebo after 52 weeks. It's designed for people with high eosinophils, a type of white blood cell linked to inflammation.
Miami, FloridaAges 40–80 - NCT07780669RecruitingPhase 3
Study of a new drug for moderate to severe COPD in smokers
This study tests a new medication (GSK5784283) for people with moderate to severe COPD who have a certain type of inflammation (eosinophilic). Participants must be on standard inhaler therapy and have a history of smoking. The trial will compare the new drug to a placebo.
Doral, FloridaAges 40–80
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,154 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.